2011 Press Releases

    Print Page  Close Window
Keyword Search
 
2013 | 2012 | 2011 | 2010 | 2009
DateTitle 
12/15/11BioMed Realty Trust Declares Fourth Quarter 2011 Common Stock and Preferred Stock Dividends
SAN DIEGO, Dec. 15, 2011 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a fourth quarter 2011 dividend of $0.20 per share of common stock.  The dividend is equivalent to an annualized dividend of $0.80 per common share. BioMed also announced that its board of directors has declared a dividend of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from October ... 
Printer Friendly Version
12/13/11Biomed Realty Trust to Acquire Remaining 80% Interest in Rogers Street Properties in Cambridge, Massachusetts for $308 Million - Increasing Ownership to 100%
Ironwood Pharmaceuticals leases additional 21,717 square feet at 301 Binney Street SAN DIEGO, Dec. 13, 2011 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that it has entered into a definitive agreement to acquire Prudential Real Estate Investors' (PREI) 80% interest in the Rogers Street properties.  BioMed previously acquired a 20% interest in the properties in April 2007 concurrent with the joint venture entered into between BioMed and PREI. ... 
Printer Friendly Version
11/14/11BioMed Realty Trust Announces Public Offering Price for 22,562,922 Shares of Common Stock
SAN DIEGO, Calif., Nov. 14, 2011 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that the public offering price for the 22,562,922 shares of its common stock previously sold to UBS Investment Bank, the sole underwriter for the offering, is $17.92 per share, for expected gross proceeds of approximately $404.3 million, before underwriting discounts and estimated expenses. UBS Investment Bank served as the sole underwriter for the offering.   The registration statement rel... 
Printer Friendly Version
11/14/11BioMed Realty Trust Announces Sale of 22,562,922 Shares of Common Stock
SAN DIEGO, Nov. 14, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced the sale of 22,562,922 shares of its common stock to UBS Investment Bank as sole underwriter in an underwritten public offering. The last reported sale price of BioMed's common stock on the New York Stock Exchange on November 11, 2011 was $18.76. The offering is subject to customary closing conditions. BioMed expects to use the net proceeds of the offering to repay the outstanding indebted... 
Printer Friendly Version
11/01/11BioMed Realty Trust Reports Third Quarter 2011 Financial Results
Total and Rental Revenues Set Record for Fourth Consecutive Quarter; AFFO Per Share Up 21% Year-Over-Year SAN DIEGO, Nov. 1, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on Providing Real Estate to the Life Science Industry®, today announced financial results for the third quarter ended September 30, 2011. Third Quarter 2011 Highlights Generated record total revenues for the fourth consecutive quarter of $115.0 mi... 
Printer Friendly Version
10/27/11BioMed Realty Trust and Meso Scale Diagnostics Announce 104,700 Square Foot Lease at 1701 Research Boulevard in Maryland
SAN DIEGO and GAITHERSBURG, Md., Oct. 27, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) and Meso Scale Diagnostics, LLC. today announced the signing of a new lease at BioMed's 1701 Research Boulevard property in Rockville, Maryland. MSD, which develops, manufactures and markets cutting edge instruments and biological assay kits, agreed to a 15 year lease for approximately 104,700 square feet. The property, which was previously vacant, is now 100% leased, less than six mo... 
Printer Friendly Version
10/24/11BioMed Realty Trust to Report 2011 Third Quarter Results
SAN DIEGO, Oct. 24, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its third quarter ended September 30, 2011 after the market closes on Tuesday, November 1, 2011. Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 9:00 a.m. Pacific Time on Wednesday, November 2, 2011 to di... 
Printer Friendly Version
09/20/11Isis Pharmaceuticals and BioMed Realty Trust Celebrate Grand Opening of New R&D Facility in Carlsbad, California
State-of-the-Art 176,000 Square Foot Building Serves as Isis' New Corporate and Research Facility SAN DIEGO, Sept. 20, 2011 /PRNewswire via COMTEX/ --Civic leaders today joined senior management from Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and BioMed Realty Trust, Inc. (NYSE: BMR) to celebrate the completion of a new 176,000 square foot build-to-suit corporate and research facility on Gazelle Court in the Carlsbad Oaks North Business Park in Carlsbad. Among the featured speakers at the cere... 
Printer Friendly Version
09/15/11BioMed Realty Trust Declares Third Quarter 2011 Common Stock and Preferred Stock Dividends
SAN DIEGO, Sept. 15, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a third quarter 2011 dividend of $0.20 per share of common stock. The dividend is equivalent to an annualized dividend of $0.80 per common share. BioMed also announced that its board of directors has declared a dividend of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from July 16, 2011 ... 
Printer Friendly Version
08/31/11BioMed Realty Announces Repurchase at Option of Holders and Redemption of 4.50% Exchangeable Senior Notes Due 2026
SAN DIEGO, Aug. 31, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (the "Company") (NYSE: BMR) announced today that holders of the 4.50% Exchangeable Senior Notes due 2026 (CUSIP No. 09064AAA9) (the "Notes") of its operating partnership, BioMed Realty, L.P. (the "Operating Partnership"), which are fully and unconditionally guaranteed by the Company, have the right to surrender their Notes for purchase by the Operating Partnership pursuant to their option (the "Put Option") under the In... 
Printer Friendly Version
08/03/11BioMed Realty Trust Reports Second Quarter 2011 Financial Results
Signed 602,500 SF of Leasing and Continued Strong Same Property Cash NOI Growth -- up 6.8% Year-Over-Year SAN DIEGO, Aug. 3, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on Providing Real Estate to the Life Science Industry®, today announced financial results for the second quarter ended June 30, 2011. Second Quarter 2011 Highlights Generated record total revenues for the third consecutive quarter of $106.8 millio... 
Printer Friendly Version
07/28/11BioMed Realty Trust and BIND Biosciences Sign New Lease at Vassar Street Property
Recently Redeveloped Property in the Cambridgeport Submarket is Now 100% Leased SAN DIEGO, July 28, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new lease with BIND Biosciences, Inc. at its Vassar Street property located in Cambridge, Massachusetts. BIND Biosciences, a biopharmaceutical company developing therapeutic targeted nanoparticles to produce best-in-class drugs, will occupy approximately 32,800 square feet of laboratory and of... 
Printer Friendly Version
07/26/11BioMed Realty Trust to Report 2011 Second Quarter Results
SAN DIEGO, Calif. - July 26, 2011 - BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its second quarter ended June 30, 2011 after the market closes on Wednesday, August 3, 2011. Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Thursday, August 4, 2011 to discuss the company's financial results and operations for the ... 
Printer Friendly Version
07/19/11BioMed Realty Trust Enters Into New $750 Million Unsecured Revolving Credit Facility
SAN DIEGO, July 19, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) announced today that the company has entered into a new $750 million unsecured revolving credit facility, replacing the previous unsecured revolving credit facility which had a maturity date of August 1, 2011. The new facility matures on July 13, 2015, but can be extended for one year to July 13, 2016 at the company's option. In addition, the terms of the new facility permit BioMed to increase the amount o... 
Printer Friendly Version
06/27/11Acorda Therapeutics to Relocate Corporate Headquarters to Ardsley Park Life Science Campus; Site Acquired and Now Managed by BioMed Realty Trust
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it plans to relocate its corporate headquarters to the Ardsley Park life science campus in Ardsley, New York, which was acquired by BioMed Realty Trust, Inc. (NYSE: BMR). Acorda has signed an agreement to lease approximately 138,000 square feet of laboratory and office space within the site for a 15-year period expected to begin in June 2012. Acorda plans to relocate all employees currently based at i... 
Printer Friendly Version
06/15/11BioMed Realty Trust Declares Second Quarter 2011 Common Stock and Preferred Stock Dividends
SAN DIEGO, June 15, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a second quarter 2011 dividend of $0.20 per share of common stock. The dividend is equivalent to an annualized dividend of $0.80 per common share. BioMed also announced that its board of directors has declared a dividend of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from April 16, 2011... 
Printer Friendly Version
06/08/11BioMed Realty Trust and Pfizer Sign New Lease at the Center for Life Science | Boston
World's Premier Life Science Research Facility is Now 98% Leased SAN DIEGO, June 8, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new ten-year lease at the Center for Life Science | Boston with Pfizer Inc. (NYSE: PFE), the world's leading biopharmaceutical company. Pfizer's Center for Therapeutic Innovation will occupy approximately 16,600 square feet of laboratory and office space on the top floor of the state-of-the-art 18-story buildi... 
Printer Friendly Version
06/06/11BioMed Realty Trust to Present at REITWeek 2011
SAN DIEGO, June 6, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) announced today that members of its executive management will present at REITWeek 2011: NAREIT's Investor Forum® in New York City on Tuesday, June 7, 2011 at approximately 11:45 a.m. Eastern Daylight Time. (Logo: http://photos.prnewswire.com/prnh/20091005/BIOMEDLOGO) A live webcast of the presentation will be available to all investors by accessing the company's website at www.biomedrealty.com. The co... 
Printer Friendly Version
05/25/11BioMed Realty Trust to Webcast Company Presentation at Investor Day 2011
SAN DIEGO, May 25, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) will webcast the company's presentation at its Investor Day 2011 to be held on Thursday, May 26, 2011 at the New York Stock Exchange. The webcast will feature presentations by Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President and Chief Operating Officer, and Greg Lubushkin, Chief Financial Officer. (Logo: http://photos.prnewswire.com/prnh/20091005/BIOMEDLOGO) The live audio w... 
Printer Friendly Version
05/04/11BioMed Realty Trust Reports First Quarter 2011 Financial Results
Sustained, Strong Execution Results in 463,000 SF of Leasing and 7.7% Year-Over-Year Increase in Same Property NOI on a Cash Basis SAN DIEGO, May 4, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on Providing Real Estate to the Life Science Industry®, today announced financial results for the first quarter ended March 31, 2011. First Quarter 2011 Highlights Generated record total revenues for the second consecutive ... 
Printer Friendly Version
05/03/11BioMed Realty Trust Signs 263,543 Square Foot Lease With Logitech at the Pacific Research Center
SAN DIEGO, May 3, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new lease with Logitech, Inc. (SIX: LOGN) (Nasdaq: LOGI) at its Pacific Research Center in Newark, California. Logitech, a world leader in products that connect people to the digital experiences they care about, agreed to a lease for 263,543 square feet of office space through February 2023 at BioMed's multi-tenant campus in San Francisco's East Bay. During the last twelve... 
Printer Friendly Version
04/27/11BioMed Realty Trust to Report 2011 First Quarter Results
SAN DIEGO, April 27, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its first quarter ended March 31, 2011 after the market closes on Wednesday, May 4, 2011. Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Thursday, May 5, 2011 to discuss the company's financial results and operations... 
Printer Friendly Version
04/12/11BioMed Realty Trust Introduces Its 2010 Online Annual Report
SAN DIEGO, April 12, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) announced today that its 2010 Online Annual Report and other proxy materials are now available at http://www.biomedrealty.com/10ar/index.html. For the third consecutive year, BioMed Realty Trust is posting its annual report in an online format following the SEC-approved electronic reporting guidelines. Entitled "The Life Science of Real Estate(TM)," the company's online annual report highlights BioMed's exc... 
Printer Friendly Version
03/30/11BioMed Realty, L.P. Announces Closing of Offering of 3.85% Senior Unsecured Notes Due 2016
SAN DIEGO, March 30, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its operating partnership subsidiary, BioMed Realty, L.P., completed a public offering of $400 million aggregate principal amount of 3.85% Senior Notes due 2016 (the "Notes"). The Notes are senior unsecured obligations of the operating partnership and are fully and unconditionally guaranteed by BioMed Realty Trust, Inc. Interest on the Notes is payable semiannually on April 15 and ... 
Printer Friendly Version
03/23/11BioMed Realty, L.P. Prices $400 Million Offering of 3.85% Senior Unsecured Notes Due 2016
SAN DIEGO, March 23, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its operating partnership subsidiary, BioMed Realty, L.P., priced a public offering of $400 million aggregate principal amount of 3.85% Senior Notes due 2016 (the "Notes"). The Notes were priced at 99.365% of the principal amount to yield 3.99% to maturity. The Notes will be senior unsecured obligations of the operating partnership and will be fully and unconditionally guaranteed by Bio... 
Printer Friendly Version
03/17/11BioMed Realty Trust Welcomes Harvard University Expansion at the Center for Life Science | Boston
World-Class 704,000 Square Foot Research Facility is Now 96% Leased SAN DIEGO, March 17, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new ten-year lease at the Center for Life Science | Boston with Harvard University, providing new expansion space for the Hansjorg Wyss Institute for Biologically Inspired Engineering at Harvard University. The Wyss Institute will occupy the second floor, comprising approximately 31,500 square feet of lab... 
Printer Friendly Version
03/14/11BioMed Realty Trust Declares First Quarter 2011 Common Stock and Preferred Stock Dividends
Increases common stock dividend by 17.6% SAN DIEGO, March 14, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a first quarter 2011 dividend of $0.20 per share of common stock, representing a 17.6% increase over the company's fourth quarter 2010 dividend of $0.17 per share. The dividend is equivalent to an annualized dividend of $0.80 per common share. BioMed also announced that its board of directors has declar... 
Printer Friendly Version
02/07/11BioMed Realty Trust Reports Fourth Quarter and Full-Year 2010 Financial Results
SAN DIEGO, Feb. 7, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on Providing Real Estate to the Life Science Industry(R), today announced financial results for the fourth quarter and full-year ended December 31, 2010. Fourth Quarter 2010 Highlights Generated record total revenues for the fourth quarter of $105.0 million, up 19.1% from $88.2 million in the same period in 2009. Increased rental revenues for th... 
Printer Friendly Version
02/03/11BioMed Realty Trust Announces Another Lease at Bridgeview Technology Park: 51,500 Square Feet Leased to Bionovo, Inc.
SAN DIEGO, Feb. 3, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced the signing of a new lease with Bionovo, Inc. (Nasdaq: BNVI) at its Bridgeview Technology Park in Hayward, California. Bionovo, a pharmaceutical company focused on the discovery and development of drug treatments for women's health and cancer, agreed to a ten-year lease for approximately 51,500 square feet at BioMed's multi-tenant research campus in the East Bay of San Francisco's technology c... 
Printer Friendly Version
01/31/11BioMed Realty Trust to Report 2010 Fourth Quarter and Year End Results
SAN DIEGO, Jan. 31, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its fourth quarter and year ended December 31, 2010 after the market closes on Monday, February 7, 2011. Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Tuesday, February 8, 2011 to discuss the company's financial resu... 
Printer Friendly Version
01/19/11BioMed Realty Trust Announces Tax Treatment of 2010 Distributions
SAN DIEGO, Jan. 19, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2010 distributions as follows: Security Description: Common Stock CUSIP: 09063H107 Ticker Symbol: BMR Record Date Payable Date Total Distribution Per Share Allocable to 2010 ... 
Printer Friendly Version
01/12/11BioMed Announces Completion of Exchange Offer for its 6.125% Senior Notes Due 2020
SAN DIEGO, Jan. 12, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its operating partnership subsidiary, BioMed Realty, L.P., has completed its exchange offer to exchange its outstanding unregistered 6.125% Senior Notes due 2020 for an equal principal amount of a new issue of 6.125% Senior Notes due 2020 pursuant to an effective registration statement on Form S-4 filed with the Securities and Exchange Commission. The terms of the new series of notes are... 
Printer Friendly Version
01/05/11BioMed Realty Trust Acquires an Additional 48,300 Square Foot Research Facility in the Torrey Pines Submarket of San Diego
Also announces two acquisitions in the Research Triangle area of North Carolina SAN DIEGO, Jan. 5, 2011 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) announced that it has acquired a life science research and development facility at 3525 John Hopkins Court comprising approximately 48,300 square feet in the Torrey Pines submarket of San Diego, California. The building is 100% leased until 2018 to the University of California, San Diego, a world renowned public research univer... 
Printer Friendly Version